Public Health Agency of Canada

As COVID-19 continues to circulate in Canada and more people are getting vaccinated, different public health measures (PHMs) may be required, based on the level of transmission and other key indicators outlined below. This interim guidance provides considerations for adjusting PHMs in the context...

The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care...

This statement contains NACI’s independent advice and recommendations, which are based upon the best current available scientific knowledge. This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product...

The National Advisory Committee on Immunization (NACI) is an External Advisory Body that provides the Public Health Agency of Canada (PHAC) with independent, ongoing and timely medical, scientific, and public health advice in response to questions from PHAC relating to immunization. This...

People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases

Presents a gateway to immunization information including vaccine safety, influenza/flu shot information, immunization schedules, the Canadian Immunization Guide, and FluWatch.

Initial supplies of authorized COVID-19 vaccines are not expected to be sufficient to offer vaccination to all Canadians in whom they are authorized for use until the fall of 2021. Therefore, recommendations to prioritize key populations for early immunization are needed in order to meet the...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

The Canada Communicable Disease Report (CCDR) is a bilingual, peer-reviewed, open-access, online scientific journal published by the Public Health Agency of Canada (PHAC). It provides timely, authoritative and practical information on infectious diseases to clinicians, public health...

The National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada (PHAC) with ongoing and timely medical, scientific, and public health advice relating to immunization.

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

To support its commitment to increasing vaccination coverage in Canada, the Government of Canada launched the Immunization Partnership Fund (IPF). This fund provides $2 to $3 million per year for projects aimed at improving vaccination coverage in Canada.